Search
Mostrar filtros
Add filters:
Use filters to refine the search results.
Results 1-2 of 2 (Search time: 0.018 seconds).
| Issue Date | Title | Author(s) |
|---|---|---|
| 2021 | KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+Locally Advanced/Metastatic NSCLC | CHO, B. C.; WU, Y.; LOPES, G.; KUDABA, I.; KOWALSKI, D. M.; TURNA, H. Z.; CASTRO JR., G. De; CAGLEVIC, C.; ZHANG, L.; KARASZEWSKA, B.; LAKTIONOV, K. K.; SRIMUNINNIMIT, V.; BONDARENKO, I.; KUBOTA, K.; YIN, L.; LIN, J.; SOUZA, F.; MOK, T. S. K. |
| 2021 | Phase 3 Study of First-Line Pembrolizumab +/- Vibostolimab (anti-TIGIT) in Patients With PD-L1-Positive Metastatic NSCLC | HELLMANN, M. D.; CHO, B. C.; JUERGENS, R.; CHENG, Y.; CASTRO JR., G. De; ERMAN, M.; BAUMAN, J. R.; TAKAHASHI, T.; SCHWARZENBERGER, P.; ZHANG, P.; PIETANZA, M. C.; YANG, J. C. |
- previous
- 1
- next